Mon.May 15, 2023

article thumbnail

‘Stunning’ change to United’s colonoscopy coverage roils physicians and patients

STAT

When gastroenterologists learned in March that UnitedHealthcare plans to barricade many colonoscopies behind a controversial and complicated process known as prior authorization, their emotions cycled rapidly between fear, shock, and outrage. The change, which the health insurer will implement on June 1, means that any United member seeking surveillance and diagnostic colonoscopies to detect cancer will first need approval from United — or else have to pay out of pocket.

363
363
article thumbnail

ASBM’s Michael Reilly Participates in IFA’s Vision Health Month Webinar  

Safe Biologics

On May 15th, ASBM Executive Director Michael Reilly participated in a webinar entitled Impact of Emerging Policies on the Vision of Older Canadians hosted by the International Federation on Ageing (IFA). As part of the celebration of the Vision Health Month, this webinar was executed to raise awareness on the importance of eye health, prevention of vision loss, and work to inform policies and practices underpinned with the principles of safe, effective and appropriate treatment, determined by th

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study: Rare genetic mutation appears to have protected second person from early Alzheimer’s

STAT

For the second time in one extended family, researchers have identified a person who seemed genetically destined to develop early Alzheimer’s, but remained cognitively sound for several more decades. Like with the first case , the scientists zeroed in on another genetic variant that seemed to be protective, overcoming the impact of the mutation that would have otherwise set this man on the course for dementia in his 40s.

257
257
article thumbnail

ASBM’s Michael Reilly Participates in IFA’s Vision Health Month Webinar  

Safe Biologics

On May 15th, ASBM Executive Director Michael Reilly participated in a webinar entitled Impact of Emerging Policies on the Vision of Older Canadians hosted by the International Federation on Ageing (IFA). As part of the celebration of the Vision Health Month, this webinar was executed to raise awareness on the importance of eye health, prevention of vision loss, and work to inform policies and practices underpinned with the principles of safe, effective and appropriate treatment, determined b

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: U.S. Supreme Court declines bid by Teva to hear ‘skinny labeling’ case with implications for generic drug access

STAT

After months of anticipation, the U.S. Supreme Court declined to hear an appeal of a lower court ruling that throws into question whether generic companies can “carve out” uses for their medicines and supply Americans with cheaper alternatives to brand-name drugs. At issue is skinny labeling, which happens when a generic company seeks regulatory approval to market its medicine for a specific use, but not other patented uses for which a brand-name drug is prescribed.

Labelling 228
article thumbnail

Years into the pandemic, only a handful of clinical trials are targeting long COVID — here’s one of them

PharmaVoice

Scientists at Stanford are testing Pfizer’s Paxlovid on long COVID symptoms and their efforts could provide clues for other conditions.

130
130

More Trending

article thumbnail

UniQure sells royalty rights to hemophilia gene therapy

BioPharma Dive

The Dutch biotech sold a portion of royalties owed by CSL Behring on sales of Hemgenix, adding to a cash pile it has built since out-licensing the treatment.

117
117
article thumbnail

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

In the early days of the Covid pandemic, gravely ill patients began to fill America’s hospitals. Hospitals ran short of essential treatment medications and were unable to source those drugs from manufacturers or from the outsourcing facilities that had been authorized by Congress in 2013 to “fill the gap” in such situations. At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary gu

article thumbnail

Holy Mole-y: Signs of Skin Cancer to Watch Out for this Summer

Community Pharmacy

With winter far behind us and those long, hot days of Texas summer ahead comes ample opportunities to get outside and absorb some Vitamin D. While we all love having some fun in the sun, too much of a good thing can become a problem, and this adage rings especially true when it comes to sunlight and skin cancer. Excessive unprotected sun exposure has been linked to an increase in skin cancer risk.

article thumbnail

Biden nominates Monica Bertagnolli to head NIH

STAT

WASHINGTON — President Biden on Monday officially announced that he would nominate National Cancer Institute Director Monica Bertagnolli to fill the long-vacant director slot at the National Institutes of Health. The cancer surgeon has led NCI — NIH’s largest institute — since last October and previously led Dana-Farber Cancer Institute’s surgical oncology unit.

223
223
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CPhO: Pharmacy First ‘supports trajectory’ towards independent prescribing in community

The Pharmacist

The chief pharmaceutical officer (CPhO) for England has welcomed the recent cash injection for clinical services in community pharmacy as a key step on the journey towards independent prescribing (IP) in the sector. David Webb added that workforce development and continued development of clinical services in community pharmacy were among his top priorities for the […] The post CPhO: Pharmacy First ‘supports trajectory’ towards independent prescribing in community appeared first on The Phar

article thumbnail

STAT+: Envision Healthcare files for bankruptcy

STAT

Physician staffing firm Envision Healthcare officially filed for Chapter 11 bankruptcy on Monday, a move that will wipe away $5.6 billion of debt and hand over ownership of the company to its creditors. Envision also plans on selling a separate subsidiary that runs outpatient surgery centers, and has already attracted two potential buyers. Envision’s bankruptcy serves as a warning for other physician staffing firms that have a lot of debt and previously relied on balance billing patients.

Hospitals 219
article thumbnail

Life Biosciences, Forge Biologics Partner for Manufacturing to Advance Gene Therapies

PharmaTech

Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.

98
article thumbnail

STAT+: Hospital-insurer tussle in Arizona puts care denials front and center

STAT

UnitedHealthcare and Phoenix Children’s Hospital are embroiled in a bitter contract dispute that would lock out families and children from care at the hospital by June if the two sides don’t come to a new agreement. And at least according to the hospital, the fight isn’t over prices, which is the traditional sticking point.

Hospitals 211
article thumbnail

New patent expiration for Novartis drug EXFORGE HCT

Drug Patent Watch

Annual Drug Patent Expirations for EXFORGE+HCT Exforge Hct is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents… The post New patent expiration for Novartis drug EXFORGE HCT appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

STAT+: In Silicon Valley, a venture capital firm gives health tech startups a crash course in getting paid

STAT

REDWOOD CITY, Calif. — Over two blustery spring days earlier this month, 30 hopeful tech entrepreneurs crowded into a downtown office here. Each founder had a bright idea for transforming health care with things like artificial intelligence, sensors, or video calls. What they didn’t know was how to get paid for it.

211
211
article thumbnail

Astellas’ nonhormonal hot flashes treatment Veozah wins FDA nod

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved Astellas Pharma’s Veozah (fezolinetant) for use against moderate to severe vasomotor symptoms caused by menopause on May 12 after some delays due to an extended review. This marks the first-ever FDA approval of a nonhormonal neurokinin 3 (NK3) receptor antagonist for use against vasomotor symptoms caused by menopause.

97
article thumbnail

Opinion: China’s complicated role in malaria control in Africa

STAT

Ghana has taken a remarkable step in the fight against malaria by becoming the first country in the world to approve the R21/Matrix-M vaccine. It’s poised to be highly effective in young children from 5 months to 36 months, the age group with the highest risk. The approval highlights the continued urgency required to combat this disease, which remains a significant threat to human health and a considerable social and economic burden.

Vaccines 207
article thumbnail

Government announces medicine VAT changes and reimbursement proposals

The Pharmacist

Contractors will need to reclaim the VAT that they paid for products supplied in accordance with serious shortage protocols (SSPs) from next month, while reimbursement processes could change as early as this summer, a government update has suggested. In a letter to contractors published on Friday afternoon on the Department of Health and Social Care […] The post Government announces medicine VAT changes and reimbursement proposals appeared first on The Pharmacist.

88
article thumbnail

STAT+: Pharmalittle: FDA OKs new kind of drug to treat hot flashes; Alzheimer’s drug could cost Medicare up to $5 billion a year

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online calls, dashing about, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So why not give it a nudge in a better direction with a delicious cup of stimulation?

193
193
article thumbnail

Innovation in small molecules: Leading companies in quinoline derivatives as anticancer agents

Pharmaceutical Technology

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Small molecules in Pharmaceuticals: Quinoline derivat

article thumbnail

NHS patients gain access to Gilead’s Hepcludex

Pharma Times

NICE’s decision will result in eligible patients using a treatment that slows or halts aspects of the illness

109
109
article thumbnail

Gilead expands Arcus partnership, with eye to inflammatory disease

BioPharma Dive

The new deal is worth up to $1 billion, and will see the two collaborators work together on up to four inflammatory disease drug targets.

102
102
article thumbnail

Positive data for Acesion’s atrial fibrillation candidates

Pharma Times

The company intends to advance AF drugs that address current risk concerns with existing therapies

115
115
article thumbnail

Nido debuts with $109M for its precision approach to brain drugs

BioPharma Dive

Backed by 5AM Ventures and Eli Lilly, the startup has advanced a drug for spinal and bulbar muscular atrophy into clinical testing.

102
102
article thumbnail

In April 2023, the healthcare industry reported 62 deals worth $22.7 bn: GlobalData

Express Pharma

In April 2023, the healthcare industry reported 62 deals worth $22.7 billion as compared to the last 12-month average (April 2022 to March 2023) of 78 deals worth $14.9 billion. Merck & Co Inc to acquire Prometheus Biosciences Inc, a clinical-stage biotechnology company for US$200 per share in cash for a total equity value of approximately $10.8 billion; Astellas Pharma Inc to acquire IVERIC bio Inc, a science-driven biopharma company focused on the discovery and development of novel treatme

84
article thumbnail

How to successfully bring your drug product to launch

BioPharma Dive

Vetter brings a proven launch management process that combines extensive experience with in-depth product knowledge.

102
102
article thumbnail

LANXESS expands Lewatit range

Express Pharma

Specialty chemicals company LANXESS has grouped together 16 new ion exchange resins and absorbents for the pharma and bioprocessing industries under its umbrella brand Lewatit. They are used in various pharma and bioprocessing applications to separate and purify biomolecules. Applications of these end products range from food and animal feeds to active pharma ingredients (APIs) that are used in medicinal products. “ Typically, our products support the separation of biomolecules from complex biom

82
article thumbnail

Isle of Man to grow cannabis business to diversify economy

The Guardian - Pharmaceutical Industry

British crown dependency hopes to license as many as 10 medicinal cannabis firms by end of 2025 The Isle of Man has for decades been dominated by offshore financial services , but now its government is planning a push for a new kind of economic growth: medicinal cannabis. The British crown dependency is hoping to license as many as 10 firms by the end of 2025 to grow and export medicinal cannabis products from the island as part of a strategy to spur development.

73
article thumbnail

Leading innovators in nucleoside chemical synthesis for the pharmaceutical industry

Pharmaceutical Technology

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Innovation in Pharmaceuticals: Nucleoside chemical sy

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. With the advent of electronic health records, social media, and other digital sources, pharmaceutical companies now have access to vast amounts of data that can be used to inform their marketing strategies. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered.

article thumbnail

Amazon Health… Third Time’s a Charm  

Fuld & Company Blog

Once again, Amazon has pivoted in its attempt to break into the US healthcare market with its acquisition of One Medical. Has it got its strategy right this time and does this herald Amazon becoming a major disrupter of the primary care sector? Back in 2018, Amazon’s acquisition of PillPack was a definite success, as part of its enabling the online giant to become a key player in the drug supply chain.

article thumbnail

GSK chases down Pfizer in 5-in-1 meningitis jab contest

pharmaphorum

GSK chases down Pfizer in 5-in-1 meningitis jab contest Phil.

98
article thumbnail

Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer

World Pharma News

Irregularities in the body's genetic coding to make proteins are linked to cancerous tumors. But most genetic material contains elements whose function isn’t clear. Could abnormalities in non-coding material also impact a person’s health, or even be linked to cancers as well?

62
article thumbnail

Drug to treat atrial fibrillation without safety issues being developed by Acesion Pharma

Outsourcing Pharma

A company says it is developing a small molecule drug without major safety issues to treat a growing number of cases of atrial fibrillation, the most common cardiac arrhythmia.

52